$DNDN upturn gap. $2.34 Treatment with PROVENGE
Post# of 63801

Treatment with PROVENGE® (sipuleucel-T) Induces
Antigen Spread Associated with Overall Survival Benefits
In Advanced Prostate Cancer 2014-05-20 08:00 ET
News Release

Website

Consensus
10-Q 5/8/14
O/S shares 159,965,114
recent trades & PRs
Stockwatch

% Buy Opinion (composite)

